earnings
confidence high
sentiment negative
materiality 0.80
Adagio Medical reports FY2024 revenue up 101% to $0.6M, net loss widens to $75M, appoints CBO
Adagio Medical Holdings, Inc.
2025-Q1 EPS reported
-$0.51
- Full year revenue $0.6M (+101% YoY); net loss $75.0M vs $36.6M prior year, driven by $49.2M impairment charge.
- Q4 revenue $137K (+76% YoY); net loss $57.4M vs $8.6M; gross margin negative 1012%.
- Cash and short-term investments $20.6M as of Dec 31, 2024.
- FULCRUM-VT pivotal study enrollment over 40%; completion target H2 2025.
- Appointed Deborah Kaster as Chief Business Officer, effective March 31, 2025.